A new study coming from New Mexico and published in the journal PLOS ONE can be added to the mounting support suggesting medical marijuana can combat the opioid epidemic. The study led by Dr. Jacob Miguel Vigil and Dr. Sarah See Stith looked at 37 chronic pain patients who used opioids habitually and enrolled in New Mexico’s medical marijuana program between 2010 and 2015, and found cannabis helped reduce opioid addiction in these patients. The researchers simultaneously looked at 29 patients who did not enroll in the medical marijuana program. Using the state’s Prescription Monitoring Program, the researchers compared opioid record between the two groups over a 21 month period. Those who used medical marijuana were 17 times more likely to stop opioid use, and 5 times more likely to reduce their daily opioid intake. Daily dosage averaged at a 47% reduction through medical marijuana use. Those who chose not to enroll in the state’s program experienced a 10% increase in dosage. The researchers hope for more in depth, randomized, and placebo-based clinical trials moving forward.
This information has been provided by Marijuana Industry News and approved by our Chief Medical Officer.